Advertisement

Evaluation of a single injection of a sustained-release formulation of moxidectin for prevention of experimental heartworm infection after 12 months in dogs

Merete Holm-Martin DVM1 and Rick Atwell BVSc, PhD2
View More View Less
  • 1 Fort Dodge Australia Pty Ltd, PO Box 6024, Baulkham Hills BC, NSW, 2153, Australia.
  • | 2 Department of Companion Animal Medicine & Surgery, School of Veterinary Science, University of Queensland, Brisbane, Qld, 4072, Australia.

Abstract

Objective—To evaluate the efficacy of a single injection of a sustained-release formulation of moxidectin in preventing heartworm (Dirofilaria immitis) infection for 12 months in dogs.

Animals—14 healthy dogs.

Procedure—Group A (nontreated control dogs; n = 6) received sterile vehicle administered SC, and group B (treated dogs; n = 6) received a sustained-release formulation of moxidectin administered SC. All dogs were housed in a heartworm-endemic area for 11.5 months, and heartworm antigen and modified Knott tests were performed monthly. All dogs (including 2 additional control dogs [group C]) were then inoculated with infective-stage larvae (L3) of D immitis, and 4.5 months later, all dogs were euthanatized and postmortem examinations were performed. Adult D immitis were counted and measured, and their age was estimated.

Results—All dogs in groups A and C were infected with young (4- to 4.5-month old) adult male and female D immitis. No dogs in group B were infected with heartworms.

Conclusions and Clinical Relevance—The age of heartworms recovered suggests that infection was the result of experimental inoculation and not natural exposure to mosquitoes during the 11.5-month period the dogs resided in a heartworm-endemic area. A single SC injection of a sustained-release formulation of moxidectin was effective in providing protection against heartworm infection after 12 months in dogs. This formulation is a convenient method of heartworm prophylaxis that could eliminate the problem of poor owner compliance. (Am J Vet Res 2004; 65:1596–1599)

Abstract

Objective—To evaluate the efficacy of a single injection of a sustained-release formulation of moxidectin in preventing heartworm (Dirofilaria immitis) infection for 12 months in dogs.

Animals—14 healthy dogs.

Procedure—Group A (nontreated control dogs; n = 6) received sterile vehicle administered SC, and group B (treated dogs; n = 6) received a sustained-release formulation of moxidectin administered SC. All dogs were housed in a heartworm-endemic area for 11.5 months, and heartworm antigen and modified Knott tests were performed monthly. All dogs (including 2 additional control dogs [group C]) were then inoculated with infective-stage larvae (L3) of D immitis, and 4.5 months later, all dogs were euthanatized and postmortem examinations were performed. Adult D immitis were counted and measured, and their age was estimated.

Results—All dogs in groups A and C were infected with young (4- to 4.5-month old) adult male and female D immitis. No dogs in group B were infected with heartworms.

Conclusions and Clinical Relevance—The age of heartworms recovered suggests that infection was the result of experimental inoculation and not natural exposure to mosquitoes during the 11.5-month period the dogs resided in a heartworm-endemic area. A single SC injection of a sustained-release formulation of moxidectin was effective in providing protection against heartworm infection after 12 months in dogs. This formulation is a convenient method of heartworm prophylaxis that could eliminate the problem of poor owner compliance. (Am J Vet Res 2004; 65:1596–1599)